Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL116376 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL987953 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL438257 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL7799602 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL17586846 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL272664 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL987771 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL9183077 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL12570287 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT | |
| SCHEMBL13566433 | 1.00 | HSD17B10 (0.45) | HSD17B10MEN1KMT2ATHRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180156810-A1 | FLUORESCENT COMPOUNDS | BIOTIUM, INC. | 2018-06-07 | — | — | US | disclosed |
| US-9791450-B2 | Fluorescent compounds | BIOTIUM, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| US-20160033520-A1 | FLUORESCENT COMPOUNDS | BIOTIUM, INC. | 2016-02-04 | — | — | US | disclosed |
| US-9097667-B2 | Fluorescent compounds | BIOTIUM, INC. (US) | 2015-08-04 | — | — | US | disclosed |
| US-8119364-B2 | Methods for generating analogs of coenzyme A | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-02-21 | — | — | US | disclosed |
| US-20090305410-A1 | FLUORESCENT COMPOUNDS | BIOTIUM, INC. (US) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090305410-A1 | FLUORESCENT COMPOUNDS | MKI67, CD68, CA5B | HSD17B10 648/4885MEN1 1677/4885KMT2A 3471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.